Gene Symbol | Pearson Correlation Coefficient |
---|---|
TECPR2 | 0.91 |
VPS52 | 0.896 |
ATG2A | 0.895 |
ARFGAP2 | 0.89 |
MAN1B1 | 0.889 |
SLC35C2 | 0.888 |
DCAF8 | 0.887 |
GPS1 | 0.886 |
SPPL2B | 0.886 |
SPG7 | 0.886 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.685 |
OR4F29 | -0.648 |
MTRNR2L6 | -0.399 |
MTRNR2L9 | -0.386 |
PABPC4L | -0.358 |
PPBP | -0.353 |
MTRNR2L10 | -0.337 |
SIX1 | -0.329 |
GSDMA | -0.319 |
SPRR4 | -0.318 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB06757 | Manganese | Small Molecule | 7439-96-5 | Approved|Nutraceutical | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C003898 | 2-anisidine | 2-anisidine results in decreased expression of TAB1 mRNA | 28089782 |
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of TAB1 mRNA" | 18648102 |
D000082 | Acetaminophen | Acetaminophen affects the expression of TAB1 mRNA | 17562736 |
D020106 | Acrylamide | Acrylamide results in increased expression of TAB1 mRNA | 28959563 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of TAB1 mRNA | 19770486 |
C547126 | AZM551248 | AZM551248 results in decreased expression of TAB1 mRNA | 22323515 |
C006780 | bisphenol A | bisphenol A affects the expression of TAB1 mRNA | 25181051 |
C089595 | cylindrospermopsin | cylindrospermopsin results in increased expression of TAB1 mRNA | 24921660 |
D003976 | Diazinon | Diazinon results in increased methylation of TAB1 gene | 22964155 |
C016366 | dibenzothiophene | dibenzothiophene results in increased expression of TAB1 mRNA | 23656968 |
D002945 | Cisplatin | Cisplatin results in decreased phosphorylation of TAB1 protein | 22006019 |
C015835 | dimethyl-4-toluidine | dimethyl-4-toluidine results in increased expression of TAB1 mRNA | 27638505 |
D004147 | Dioxins | Dioxins affects the expression of TAB1 mRNA | 20463971 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TAB1 mRNA | 25613284 |
C544151 | jinfukang | jinfukang results in increased expression of TAB1 mRNA | 27392435 |
D008345 | Manganese | Manganese binds to TAB1 protein | 16879102 |
C013592 | mangiferin | mangiferin results in decreased expression of TAB1 mRNA | 15135318 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of TAB1 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of TAB1 mRNA" | 25554681 |
C464660 | obeticholic acid | obeticholic acid results in decreased expression of TAB1 mRNA | 27939613 |
D019821 | Simvastatin | Simvastatin results in decreased activity of [MAP3K7 protein co-treated with TAB1 protein] | 17277159 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of TAB1 mRNA | 21570461 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TAB1 mRNA | 25613284 |
C009495 | titanium dioxide | titanium dioxide affects the expression of TAB1 mRNA | 17656681 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of TAB1 mRNA" | 19682533 |
D014520 | Urethane | Urethane results in decreased expression of TAB1 mRNA | 28818685 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004722 | protein serine/threonine phosphatase activity | - | IEA | - |
GO:0005515 | protein binding | - | IPI | 10094049 11460167 11847341 14743216 16845370 17620599 19026643 19875381 21900206 21903422 21988832 22158122 25241761 25260751 27505673 |
GO:0008047 | enzyme activator activity | - | TAS | 8638164 |
GO:0019209 | kinase activator activity | - | IEA | - |
GO:0044877 | protein-containing complex binding | - | IEA | - |
GO:0048273 | mitogen-activated protein kinase p38 binding | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000185 | activation of MAPKKK activity | - | IEA | - |
GO:0000187 | activation of MAPK activity | - | TAS | - |
GO:0001701 | in utero embryonic development | - | IEA | - |
GO:0002223 | stimulatory C-type lectin receptor signaling pathway | - | TAS | - |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | - | TAS | - |
GO:0003007 | heart morphogenesis | - | IEA | - |
GO:0003279 | cardiac septum development | - | IEA | - |
GO:0006470 | protein dephosphorylation | - | IEA | - |
GO:0007179 | transforming growth factor beta receptor signaling pathway | - | IEA | - |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | - | TAS | - |
GO:0007254 | JNK cascade | - | TAS | - |
GO:0016579 | protein deubiquitination | - | TAS | - |
GO:0030324 | lung development | - | IEA | - |
GO:0035904 | aorta development | - | IEA | - |
GO:0038095 | Fc-epsilon receptor signaling pathway | - | TAS | - |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | - | TAS | - |
GO:0060976 | coronary vasculature development | - | IEA | - |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | - | TAS | - |
GO:0070498 | interleukin-1-mediated signaling pathway | - | TAS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005829 | cytosol | - | IDA | - |
GO:0005829 | cytosol | - | TAS | - |
GO:0010008 | endosome membrane | - | TAS | - |
GO:0016607 | nuclear speck | - | IDA | - |
GO:0032991 | protein-containing complex | - | IEA | - |
KEGG ID | KEGG Term |
---|---|
hsa04010 | MAPK signaling pathway |
hsa04380 | Osteoclast differentiation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04621 | NOD-like receptor signaling pathway |
hsa05140 | Leishmaniasis |
hsa05145 | Toxoplasmosis |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1280215 | Cytokine Signaling in Immune system | TAS |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | TAS |
R-HSA-166058 | MyD88:Mal cascade initiated on plasma membrane | TAS |
R-HSA-166166 | MyD88-independent TLR4 cascade | TAS |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | TAS |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | TAS |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | TAS |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | TAS |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | TAS |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | TAS |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | TAS |
R-HSA-168249 | Innate Immune System | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-168638 | NOD1/2 Signaling Pathway | TAS |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | TAS |
R-HSA-168898 | Toll-Like Receptors Cascades | TAS |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | TAS |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | TAS |
R-HSA-2871837 | FCERI mediated NF-kB activation | TAS |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-445989 | TAK1 activates NFkB by phosphorylation and activation of IKKs complex | TAS |
R-HSA-446652 | Interleukin-1 family signaling | TAS |
R-HSA-448424 | Interleukin-17 signaling | TAS |
R-HSA-449147 | Signaling by Interleukins | TAS |
R-HSA-450294 | MAP kinase activation | TAS |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | TAS |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | TAS |
R-HSA-5357956 | TNFR1-induced NFkappaB signaling pathway | TAS |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | TAS |
R-HSA-5621481 | C-type lectin receptors (CLRs) | TAS |
R-HSA-5688426 | Deubiquitination | TAS |
R-HSA-5689880 | Ub-specific processing proteases | TAS |
R-HSA-597592 | Post-translational protein modification | TAS |
R-HSA-73887 | Death Receptor Signalling | TAS |
R-HSA-75893 | TNF signaling | TAS |
R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | TAS |
R-HSA-9020702 | Interleukin-1 signaling | TAS |
R-HSA-937042 | IRAK2 mediated activation of TAK1 complex | TAS |
R-HSA-937061 | TRIF(TICAM1)-mediated TLR4 signaling | TAS |
R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | TAS |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | TAS |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | TAS |
R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | TAS |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
26884850 | Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance. (2015) | Zhu J | Int J Clin Exp Pathol |